VISUDYNE

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug VISUDYNE contains one active pharmaceutical ingredient (API):

1	Verteporfin UNII 0X9PA28K43 - VERTEPORFIN
	Verteporfin, also referred to as benzoporphyrin derivative monoacids (BPD-MA) consists of a 1:1 mixture of the equally active regioisomers BPD-MAC and BPD-MAD. It produces cytotoxic agents only when activated by light in the presence of oxygen. The selectivity of PDT using verteporfin is based, in addition to the localised light exposure, on selective and rapid uptake and retention of verteporfin by rapidly proliferating cells including the endothelium of choroidal neovasculature.
	Read more about Verteporfin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VISUDYNE Powder for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01LA01	Verteporfin	S Sensory organs → S01 Ophthalmologicals → S01L Ocular vascular disorder agents → S01LA Antineovascularisation agents
Discover more medicines within S01LA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	526516402175210
CA	Health Products and Food Branch	02242367
EE	Ravimiamet	1012633, 1837368
ES	Centro de información online de medicamentos de la AEMPS	00140001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	002616
FR	Base de données publique des médicaments	64637807
GB	Medicines & Healthcare Products Regulatory Agency	48119
HK	Department of Health Drug Office	48053
JP	医薬品医療機器総合機構	1319401F1026
LT	Valstybinė vaistų kontrolės tarnyba	1009514
NL	Z-Index G-Standaard, PRK	58963
NZ	Medicines and Medical Devices Safety Authority	9059
PL	Rejestru Produktów Leczniczych	100106416
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W08282001
SG	Health Sciences Authority	11608P
TR	İlaç ve Tıbbi Cihaz Kurumu	8682340179039
US	FDA, National Drug Code	0187-5600
ZA	Health Products Regulatory Authority	35/15.4/0139